Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
TDUP
|
Jack R Lazar
Director |
BUY
Open market or private purchase
|
Direct | 7,142 Added 28.57% |
$99,988
$14.0 p/Share
|
Mar 30
2021 |
|
MUX
|
Anna Man Yue Ladd Kruger
CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct | 20,000 Added 50.0% |
$20,600
$1.03 p/Share
|
Mar 30
2021 |
|
IKNA
|
David P Bonita |
BUY
Open market or private purchase
|
Indirect | 423,400 Added 21.9% |
$6,774,400
$16.0 p/Share
|
Mar 30
2021 |
|
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 500 Added 0.41% |
$8,700
$17.4 p/Share
|
Mar 30
2021 |
|
EP
|
Tony Kamin
Director |
BUY
Open market or private purchase
|
Indirect | 428,571 Added 36.41% |
$150,000
$0.35 p/Share
|
Mar 30
2021 |
|
IGXT
|
Bernard Boudreau
Director |
BUY
Open market or private purchase
|
Direct | 12,500 Added 8.45% |
$5,000
$0.4 p/Share
|
Mar 30
2021 |
|
DSE
|
Css LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 2,889 Added 0.61% |
$20,859
$7.22 p/Share
|
Mar 30
2021 |
|
IKNA
|
Jean Francois Formela |
BUY
Open market or private purchase
|
Indirect | 125,000 Added 12.5% |
$2,000,000
$16.0 p/Share
|
Mar 30
2021 |
|
IKNA
|
Atlas Venture Fund Xi, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 125,000 Added 12.5% |
$2,000,000
$16.0 p/Share
|
Mar 30
2021 |
|
VGR
|
Paul V Carlucci |
BUY
Open market or private purchase
|
Direct | 110 Added 0.74% |
$1,553
$14.12 p/Share
|
Mar 30
2021 |
|
TWOA
|
Sponsor Two
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 600,000 Added 50.0% |
$6,000,000
$10.0 p/Share
|
Mar 29
2021 |
|
TWOA
|
Gautam Gupta
Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 600,000 Added 0.0% |
$6,000,000
$10.0 p/Share
|
Mar 29
2021 |
|
TWOA
|
Kevin Hartz
Co-Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 600,000 Added 0.0% |
$6,000,000
$10.0 p/Share
|
Mar 29
2021 |
|
TWOA
|
Troy Steckenrider Iii
Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect | 600,000 Added 0.0% |
$6,000,000
$10.0 p/Share
|
Mar 29
2021 |
|
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 100 Added 0.08% |
$1,702
$17.02 p/Share
|
Mar 29
2021 |
|
VZIO
|
Julia S Gouw |
BUY
Open market or private purchase
|
Direct | 35,000 Added 50.0% |
$735,000
$21.0 p/Share
|
Mar 29
2021 |
|
REVG
|
Rodney M Rushing
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 16,750 Added 1.73% |
$301,165
$17.98 p/Share
|
Mar 29
2021 |
|
EAD
|
Christopher M Lee |
BUY
Open market or private purchase
|
Direct | 5,000 Added 13.61% |
$41,850
$8.37 p/Share
|
Mar 29
2021 |
|
EOD
|
Christopher M Lee |
BUY
Open market or private purchase
|
Direct | 5,000 Added 25.0% |
$25,950
$5.19 p/Share
|
Mar 29
2021 |
|
GORO
|
Ronald Little
Director |
BUY
Open market or private purchase
|
Indirect | 20,000 Added 33.33% |
$52,000
$2.6 p/Share
|
Mar 29
2021 |
|
NAVB
|
Malcolm G Witter
Director |
BUY
Open market or private purchase
|
Direct | 21,500 Added 31.39% |
$44,505
$2.07 p/Share
|
Mar 29
2021 |
|
FEIM
|
Edenbrook Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 0.06% |
$11,460
$11.46 p/Share
|
Mar 29
2021 |
|
GBDC
|
David Golub
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.1% |
$29,960
$14.98 p/Share
|
Mar 29
2021 |
|
GBDC
|
Lawrence E Golub
Chairman |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.1% |
$29,960
$14.98 p/Share
|
Mar 29
2021 |
|
WMPN
|
Jill Mc Menamin Ross
EVP & CRCO |
BUY
Open market or private purchase
|
Indirect | 4,368 Added 49.72% |
$50,014
$11.45 p/Share
|
Mar 29
2021 |
|
AGRX
|
Jason Butch
Principal Accounting Officer |
BUY
Open market or private purchase
|
Direct | 1,358 Added 6.36% |
$2,702
$1.99 p/Share
|
Mar 29
2021 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 28 Added 0.21% |
$41,338
$1476.34 p/Share
|
Mar 29
2021 |
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.25% |
$4,429
$1476.34 p/Share
|
Mar 29
2021 |
|
PFSI
|
Mfn Partners, LP
Director |
BUY
Open market or private purchase
|
Direct | 94,106 Added 5.87% |
$6,060,427
$64.4 p/Share
|
Mar 29
2021 |
|
GMS
|
Coliseum Capital Management, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 80,000 Added 1.74% |
$3,184,800
$39.81 p/Share
|
Mar 29
2021 |
|
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.18% |
$1,782
$2.64 p/Share
|
Mar 29
2021 |
|
PFSI
|
Farhad Nanji
Director |
BUY
Open market or private purchase
|
Indirect | 94,106 Added 5.87% |
$6,060,427
$64.4 p/Share
|
Mar 29
2021 |
|
TSI
|
Laird Landmann
PORTFOLIO MANAGER |
BUY
Open market or private purchase
|
Direct | 3,200 Added 0.76% |
$18,144
$5.67 p/Share
|
Mar 29
2021 |
|
FXNC
|
Gerald F Smith Jr
Director |
BUY
Open market or private purchase
|
Direct | 4,255 Added 10.21% |
$76,718
$18.03 p/Share
|
Mar 29
2021 |
|
NYC
|
Edward M Weil Jr.
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 1.23% |
$1,342
$8.95 p/Share
|
Mar 29
2021 |
|
TURN
|
Alicia M Gift
Treasurer, Secretary |
BUY
Open market or private purchase
|
Direct | 500 Added 2.15% |
$3,675
$7.35 p/Share
|
Mar 29
2021 |
|
TAYD
|
Timothy John Sopko
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 1,053 Added 25.98% |
$11,520
$10.94 p/Share
|
Mar 29
2021 |
|
CYTH
|
Markus Sieger
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 12.88% |
$81,000
$8.1 p/Share
|
Mar 29
2021 |
|
CYTH
|
Joshua M Fine
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 50 Added 0.29% |
$370
$7.4 p/Share
|
Mar 29
2021 |
|
CYTH
|
Sharon Hemond Hrynkow
Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct | 1,000 Added 5.17% |
$7,460
$7.46 p/Share
|
Mar 29
2021 |
|
CYTH
|
Francis Patrick Ostronic
Director |
BUY
Open market or private purchase
|
Direct | 3,000 Added 4.65% |
$22,500
$7.5 p/Share
|
Mar 29
2021 |
|
CYTH
|
Jeffrey Tate
Chief Operating Officer |
BUY
Open market or private purchase
|
Direct | 2,000 Added 6.86% |
$15,000
$7.5 p/Share
|
Mar 29
2021 |
|
SEMR
|
Roman Simonov
Director |
BUY
Open market or private purchase
|
Direct | 13,000 Added 50.0% |
$182,000
$14.0 p/Share
|
Mar 29
2021 |
|
TRIP
|
Certares Ltrip LLC |
BUY
Open market or private purchase
|
Indirect | 1,713,859 Added 50.0% |
-
|
Mar 29
2021 |
|
BWFG
|
James M Garnett Jr
Director |
BUY
Open market or private purchase
|
Direct | 94 Added 50.0% |
$2,491
$26.5 p/Share
|
Mar 29
2021 |
|
BWFG
|
Lawrence B Seidman
Director |
BUY
Open market or private purchase
|
Direct | 139 Added 50.0% |
$3,684
$26.5 p/Share
|
Mar 29
2021 |
|
MTEM
|
Target N V Biotech |
BUY
Open market or private purchase
|
Direct | 80,000 Added 0.98% |
$916,000
$11.45 p/Share
|
Mar 29
2021 |
|
GTIM
|
Charles E Jobson |
BUY
Open market or private purchase
|
Indirect | 6,189 Added 1.84% |
$24,756
$4.0 p/Share
|
Mar 29
2021 |
|
BNKL
|
Joseph R Martin
Director |
BUY
Open market or private purchase
|
Direct | 26,430 Added 50.0% |
-
|
Mar 29
2021 |
|
BNKL
|
Audrey Thevenon
Director |
BUY
Open market or private purchase
|
Direct | 26,430 Added 50.0% |
-
|
Mar 29
2021 |